Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual MeetingBusiness Wire • 05/01/24
Chimera Investment Corporation Announces Date of First Quarter 2024 Financial Results and Conference CallBusiness Wire • 04/24/24
Chimera Investment Corporation Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference CallBusiness Wire • 01/30/24